The risk of lymph node metastasis with positive peritoneal cytology in endometrial cancer

International Journal of Gynecological Cancer

Volumn 23, Issue 1, 2013, Pages 90-97

  Garg, Gunjal ^a   Gao, Feng ^a   Wright, Jason D ^b   Hagemann, Andrea R ^a   Zighelboim, Israel ^a   Mutch, David G ^a   Powell, Matthew A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b School of Medicine ^*  (United States)

Author keywords

Endometrial cancer; Lymph node; Metastasis; Peritoneal cytology

Indexed keywords

ADULT; AGED; ARTICLE; ASCITES FLUID CYTOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER PROGNOSIS; CANCER REGISTRY; CLEAR CELL CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENDOMETRIOID ADENOCARCINOMA; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSITIVE PERITONEAL CYTOLOGY; PRIORITY JOURNAL; RISK FACTOR; UTERUS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, ENDOMETRIOID; CYTODIAGNOSIS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PERITONEAL NEOPLASMS; PROGNOSIS; RISK FACTORS;

EID: 84872348997     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1097/IGC.0b013e318275afd2     Document Type: Article

References (26)

1. Siegel R, Ward E, Brawley O, et al. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61: 212-236.
2. Kilgore LC, Partridge EE, Alvarez RD, et al. Adenocarcinoma of the endometrium: survival comparisons of patients with and without pelvic node sampling. Gynecol Oncol. 1995;56:29-33.
3. Trimble EL, Kosary C, Park RC. Lymph node sampling and survival in endometrial cancer. Gynecol Oncol. 1998;71:340-343.
4. Cragun JM, Havrilesky LJ, Calingaert B, et al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J Clin Oncol. 2005;23:3668-3675.
5. Mohan DS, Samuels MA, Selim MA, et al. Long-termoutcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol Oncol. 1998;70:165-171.
6. Chan JK, Cheung MK, Huh WK, et al. Therapeutic role of lymph node resection in endometrioid corpus cancer: a study of 12,333 patients. Cancer. 2006;107:1823-1830.
7. Uccella S, Podratz KC, Aletti GD, et al. Re: Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst. 2009;101:897-898; author reply, 8-9.
8. Amant F, Neven P, Vergote I. Lymphadenectomy in endometrial cancer. Lancet. 2009;373:1169-1170; author reply, 70-71.
9. Uccella S, Podratz KC, Aletti GD, et al. Lymphadenectomy in endometrial cancer. Lancet. 2009;373:1170; author reply -1.
10. Creasman WT, Morrow CP, Bundy BN, et al. Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study. Cancer. 1987;60(suppl 8):2035-2041.
11. Lampe B, Kurzl R, Hantschmann P. Prognostic factors that predict pelvic lymph node metastasis from endometrial carcinoma. Cancer. 1994;74:2502-2508.
12. Kamura T, Yahata H, Shigematsu T, et al. Predicting pelvic lymph node metastasis in endometrial carcinoma. Gynecol Oncol. 1999;72:387-391.
13. Mariani A,Webb MJ, Keeney GL, et al. Predictors of lymphatic failure in endometrial cancer. Gynecol Oncol. 2002;84:437-442.
14. Kim HS, Song YS. International Federation of Gynecology and Obstetrics (FIGO) staging system revised: what should be considered critically for gynecologic cancer? J Gynecol Oncol. 2009;20:135-136.
15. Havrilesky LJ, Cragun JM, Calingaert B, et al. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer. Gynecol Oncol. 2007;104:401-405.
16. Bansal S, Buck AM, Herzog TJ, et al. Stage IIIA endometrial carcinoma: outcome and predictors of survival. Obstet Gynecol. 2009;114:100-105.
17. Tebeu PM, Popowski Y, Verkooijen HM, et al. Positive peritoneal cytology in early-stage endometrial cancer does not influence prognosis. Br J Cancer. 2004;91:720-724.
18. Fadare O, Mariappan MR, Hileeto D, et al. Upstaging based solely on positive peritoneal washing does not affect outcome in endometrial cancer. Mod Pathol. 2005;18: 673-680.
19. Takeshima N, Nishida H, Tabata T, et al. Positive peritoneal cytology in endometrial cancer: enhancement of other prognostic indicators. Gynecol Oncol. 2001;82: 470-473.
20. Taskiran C, Yuce K, Geyik PO, et al. Predictability of retroperitoneal lymph node metastasis by using clinicopathologic variables in surgically staged endometrial cancer. Int J Gynecol Cancer. 2006;16:1342-1347.
21. Imachi M, Tsukamoto N, Matsuyama T, et al. Peritoneal cytology in patients with endometrial carcinoma. Gynecol Oncol. 1988;30:76-86.
22. Surveillance E, and End Results (SEER) Program (www.seer.cancer.gov) SEER*Stat Database: Incidence - SEER 17 Regs Limited-Use + Hurricane Katrina Impacted Louisiana Cases, Nov 2008 Sub (1973-2006 varying)-Linked To County Attributes-Total U.S., 1969-2006 Counties, National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2009, based on the November 2008 submission.
23. Obermair A, Geramou M, Tripcony L, et al. Peritoneal cytology: impact on disease-free survival in clinical stage I endometrioid adenocarcinoma of the uterus. Cancer Lett. 2001;164:105-110.
24. Kasamatsu T, Onda T, Katsumata N, et al. Prognostic significance of positive peritoneal cytology in endometrial carcinoma confined to the uterus. Br J Cancer. 2003;88:245-250.
25. Saga Y, Imai M, Jobo T, et al. Is peritoneal cytology a prognostic factor of endometrial cancer confined to the uterus? Gynecol Oncol. 2006;103:277-280.
26. Lee CM, Slomovitz BM, Greer M, et al. Practice patterns of SGO members for stage IIIA endometrial cancer. Gynecol Oncol. 2005;98:77-83.